Sherry LaPorte

Sherry LaPorte has a long and varied work experience. Sherry began as a graduate student at the University of California, San Francisco in 1993. Sherry then moved on to become a Postdoctoral Fellow at UCSF at San Francisco General Hospital in 2001. In 2004, they became a Postdoctoral Research Fellow at Stanford University. In 2006, they became a Senior Scientist at Rinat Neuroscience. From 2007 to 2011, they worked at Pfizer as a Principal Scientist, where they were involved in Antibody & Protein Engineering, X-ray crystal structure determination, antibody affinity maturation, antigen engineering for membrane protein targets, chimeric antibodies and antigens, and developing models for bispecific anti- Beta-amyloid targeting antibodies. Sherry then moved to CytomX Therapeutics, where they held the roles of Senior Scientist Cancer Immunology and Research Scientist Protein Engineering from 2011 to 2017. In 2017, they became the Director of Antibody Research at Vivace Therapeutics, Inc. and in 2018, they became the Senior Director Biologics Lead Engineering at JBIO/Janssen. Sherry is currently the Director Biotherapeutics Engineering at The Janssen Pharmaceutical Companies of Johnson & Johnson, a position they have held since 2019.

Sherry LaPorte obtained their Bachelor's Degree in Pharmacy from the University of Connecticut. Sherry then went on to pursue their PhD in Pharmaceutical Chemistry (Biophysics) from the University of California, San Francisco from 1993 to 2000. Following this, they completed two post-doctoral positions; one in Immunology (Structural Biology) from 2003 to 2006 at Stanford University School of Medicine, and one in Molecular Biology from 2001 to 2003 at the University of California, San Francisco - School of Medicine. Sherry also holds a Professional Licensed Pharmacist, R.Ph. certification from the State of Connecticut.